Author: Fengbo Ren
-
Fovus Joins Ansys Technology Partner Program
—
by
May 7, 2025 – Fovus announced today that they have joined the Ansys Technology Partner Program. The partnership enables joint customers to accelerate Ansys’ simulation solutions through powerful high-performance computing (HPC), ultimately facilitating improved product performance and shortened time-to-market. Fovus is an AI-powered, serverless high-performance computing (HPC) platform delivering intelligent, scalable, and cost-efficient supercomputing power…
-
Fovus Achieves SOC 2 Type II Compliance: Strengthening Trust and Data Security
—
by
May 2, 2025 – We’re proud to announce that Fovus has officially achieved SOC 2 Type II compliance, a significant milestone in our commitment to safeguarding customer data and maintaining the highest standards of security and privacy. SOC 2 (System and Organization Controls 2), developed by the American Institute of Certified Public Accountants (AICPA), is…
-
Fovus Delivers OpenMM Molecular Dynamics Simulations for as Low as $6.59/µs, as fast as 3359 ns/day
—
by
OpenMM is a high-performance toolkit for molecular simulations that is widely used in research domains such as computational chemistry, structural biology, and drug discovery. Known for its flexibility, GPU acceleration, and Python interface, OpenMM makes it easy to prototype new simulation methods or run standard molecular dynamics (MD) simulations at scale. However, despite its strengths,…
-
Fovus Achieves AWS High Performance Computing (HPC) Competency Status
—
by
April 23, 2025 – Fovus announced today that it has achieved the Amazon Web Services (AWS) High Performance Computing (HPC) Competency. This designation recognizes Fovus as an AWS Partner Network (APN) member that has met the rigorous technical validation requirements of AWS and demonstrated proven customer success delivering performance-optimized HPC solutions on AWS. Fovus is…
-
Unlocking Large-Scale Vina GPU Docking with Fovus: Starting from $0.95 per 10,000 Ligand Screening
—
by
Vina GPU is an advanced molecular docking software that leverages GPU acceleration to increase the speed and efficiency of virtual screening workflows significantly. Built upon the popular AutoDock Vina framework, Vina GPU accelerates the docking process by running tasks on massively parallel GPU architectures, making it possible to screen millions (or even billions) of ligands…
-
Fovus Launches Availability in AWS Marketplace
—
by
April 2, 2025 – Fovus announced today that it is now available in AWS Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on Amazon Web Services (AWS). Fovus is an AI-powered, serverless high-performance computing (HPC) platform delivering…
-
Unlocking New Heights in Computational Drug Discovery: How Fovus Empowered a Series B Biotech Startup to Scale Faster by 96x and Reduce Costs by 5.5x
—
by
A stealth Series B biotech startup focused on developing innovative therapies faced significant challenges in managing its cloud-based high-performance computing (HPC) workflows. The company’s computational workloads included high-throughput virtual screening (HTVS), molecular docking, molecular dynamics simulations, and AI-augmented HTVS; each requiring immense computational power. However, managing cloud infrastructure, optimizing HPC strategies, and scaling clusters created…
-
Optimizing MegaDock with Fovus: $3.09 per 1,000 Antibody-Antigen Docking
—
by
MegaDock Overview MegaDock 4.0 is a high-throughput protein-protein docking software designed for large-scale virtual screening applications. It employs a fast Fourier transform (FFT)–based docking method that allows it to leverage GPU acceleration, setting it apart from traditional CPU-based docking tools. This GPU utilization makes MegaDock well-suited for massive protein-protein docking workloads with its large-scale docking…
-
Achieving Cost-Efficient Boltz-1 Simulations on Fovus at $0.1 per Biomolecular Structure Prediction
—
by
Boltz-1 is a state-of-the-art open-source model that predicts biomolecular structures, including proteins, RNA, DNA, and other molecular interactions. Unlike its proprietary counterparts, it also supports modified residues, covalent ligands, and glycans, allowing for a broader range of applications. By conditioning predictions on specified interaction pockets or contacts, Boltz-1 offers a level of flexibility that makes…